Trial Profile
The influence of rebamipide eyedrops towards the glutathione contents of the conjunctival epithelial cells
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Dry eyes
- Focus Pharmacodynamics
- 08 Jul 2014 New trial record